End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.09 USD | +1.33% | -9.24% | -11.74% |
Mar. 19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Sipai Health Technology Expects to Narrow Loss in Full Year 2023 | MT |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.74% | 594M | - | ||
-34.16% | 14.83B | B- | ||
-24.55% | 12.04B | B | ||
+14.96% | 6.44B | C | ||
-25.24% | 6.52B | B | ||
-8.01% | 6.15B | C+ | ||
-2.34% | 4.64B | D- | ||
+60.00% | 4.62B | C | ||
-8.10% | 3.93B | B | ||
-11.16% | 3.49B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 314 Stock
- Ratings Sipai Health Technology Co., Ltd.